We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHIC
11301
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
$102K ﹤0.01%
10,321
-400,148
-97% -$3.95M
MUX icon
11302
McEwen Inc
MUX
$1.15B
$101K ﹤0.01%
23,050
-58,360
-72% -$363K
ORGN
11303
PUT
DELISTED
Origin Materials
ORGN
$101K ﹤0.01%
660
-67
-9% -$12.8K
SGHC icon
11304
PUT
SGHC Ltd
SGHC
$6.76B
$101K ﹤0.01%
+24,600
New +$189K
UAVS icon
11305
CALL
AgEagle Aerial Systems
UAVS
$63.9M
$101K ﹤0.01%
156
+126
+420% +$105K
NESR
11306
PUT
National Energy Services Reunited Corp
NESR
$3.66B
$101K ﹤0.01%
+14,900
New +$108K
CELL
11307
PUT
DELISTED
PhenomeX Inc. Common Stock
CELL
$101K ﹤0.01%
20,300
-13,000
-39% -$68.1K
CO
11308
DELISTED
Global Cord Blood Corporation
CO
$101K ﹤0.01%
33,974
+3,471
+11% +$10.8K
ADAP
11309
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
$100K ﹤0.01%
58,600
+31,500
+116% +$54.1K
AEVA
11310
Aeva Technologies
AEVA
$1.62B
$100K ﹤0.01%
6,374
-35,806
-85% -$590K
LU icon
11311
PUT
Lufax Holding
LU
$1.3B
$100K ﹤0.01%
4,175
-10,775
-72% -$250K
NINE
11312
DELISTED
Nine Energy Service
NINE
$100K ﹤0.01%
37,683
-55,264
-59% -$166K
ORIC icon
11313
PUT
Oric Pharmaceuticals
ORIC
$1.44B
$100K ﹤0.01%
+22,400
New +$89.4K
ZH
11314
CALL
Zhihu
ZH
$272M
$100K ﹤0.01%
9,317
-1,450
-13% -$15.6K
SBT
11315
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$100K ﹤0.01%
17,619
-14,898
-46% -$97.5K
SOLO
11316
PUT
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$100K ﹤0.01%
73,800
+2,600
+4% +$4.29K
CLAS.U
11317
DELISTED
Class Acceleration Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
CLAS.U
$100K ﹤0.01%
10,192
-125
-1% -$1.23K
EXG icon
11318
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.05B
$99K ﹤0.01%
+12,849
New +$111K
ISSC icon
11319
PUT
Innovative Solutions & Support
ISSC
$412M
$99K ﹤0.01%
13,700
KOPN icon
11320
CALL
Kopin
KOPN
$1.02B
$99K ﹤0.01%
88,800
+7,000
+9% +$10.5K
RSI icon
11321
PUT
Rush Street Interactive
RSI
$2.96B
$99K ﹤0.01%
21,200
-41,800
-66% -$249K
VERI icon
11322
PUT
Veritone
VERI
$116M
$99K ﹤0.01%
15,100
+800
+6% +$8.07K
IMGN
11323
PUT
DELISTED
Immunogen Inc
IMGN
$99K ﹤0.01%
21,900
-44,300
-67% -$192K
NSTC.U
11324
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
$99K ﹤0.01%
10,102
-279
-3% -$2.74K
IVDG
11325
DELISTED
Invesco Focused Discovery Growth ETF
IVDG
$99K ﹤0.01%
+10,576
New +$108K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.